Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Similar Companies999
Arrogene
Arrogene develops nano-biopolymers and technologies for cancer therapeutics and diagnostics.
Sector
Subsector
Keywords
Location
total rounds
total raised
Duo Oncology
Duo Oncology develops nanoparticle technology to cure established tumors.
Sector
Subsector
Keywords
Location
total rounds
total raised
ZTI Biosciences
ZTI Biosciences is a South Korean company that develops nanomedicine therapeutics for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cellics Therapeutics
Cellics develops innovative biomimetic nanomedicines to treat and prevent diseases.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds11
Number of Funding Rounds
Money Raised
Their latest funding was raised on 04.12.2023. Their latest investor Johnson & Johnson Innovation – JJDC. Their latest round Post-IPO Equity
Johnson & Johnson Innovation – JJDC
JJDC helps innovative healthcare ideas become real solutions for patients.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
Johnson & Johnson Innovation – JJDC
JJDC helps innovative healthcare ideas become real solutions for patients.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Apicap
APICAP offers innovative investment opportunities for institutional and private investors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Seventure Partners
Seventure Partners is a French venture capital firm specializing in technology and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Laurent Levy
Laurent LEVY, Ph.D., co-founder and President of the Executive Board: Laurent holds a doctorate in physical chemistry, specialized in nanomaterials, from the Pierre and Marie Curie University (Paris) and from the CEA (Commissariat à l’Énergie Atomique et aux Énergies Alternatives) and a DEA (advanced studies and diplomas) in physics of condensed matter from the UPVI-ESPCI (Paris). He has extensive experience in sciences and techniques related to nanotechnologies, a field in which he worked for more than 10 years. His research at the frontier of biotechnology and nanotechnologies has resulted in the development of a number of concrete applications such as NanoXray, which could open a new method for cancer treatment. For many years, Laurent was a consultant in the development of application of nanotechnologies with large companies such as Sanofi (pharma), Guerbet (medical imaging), Rhodia (chemistry), as well as for biotechnology start-ups. Laurent is the author of 35 international scientific publications and communications, has applied for several patents and completed his training by a post-doctoral fellowship at the Institute for Lasers, Photonics and Biophotonics, SUNY (State University of New York), Buffalo, USA.
current job
organization founded
Laurent Levy
Employee Profiles6
Mikaela Dimitriu
Vice President Global Head Medical Affairs
Activity
Recent News17
The graph reveals the ratio (%) of positive news articles in a chosen time range